Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Kidney Biopsy Market From 2025 To 2029?

There has been a significant increase in the size of the kidney biopsy market in the past few years. The market, which is projected to rise from $2.14 billion in 2024 to $2.27 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 5.8%. This growth in previous years is due to a surge in chronic kidney diseases, increased knowledge about early diagnosis, a boom in the elderly population, and the growth of healthcare infrastructure. The government’s enhanced initiatives for managing kidney disease and the rising awareness about kidney health have also contributed to this market expansion.

What Is the Projected Market Size of the Kidney Biopsy Market?

In the coming years, the kidney biopsy market is projected to experience substantial growth, with predictions indicating a rise to $2.8 billion by 2029 at a compound annual growth rate (CAGR) of 5.4%. This projected upturn within the forecast period is largely owed to several contributing factors, including a notable increase in kidney related illnesses, expanded healthcare spending, heightened awareness surrounding early detection, a growing elderly demographic, an uptick in demand for minimally invasive procedures, and a rise in research activities. Foreseen trends within the forecast timeline also encompass advancements in biopsy technology, the adoption of minimally invasive procedures, progressive developments in imaging technologies, the integration of artificial intelligence for improved accuracy, and technological innovations regarding biopsy devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16458&type=smp

Who are the Major Competitors in the Kidney Biopsy Market Outlook?

Major companies operating in the kidney biopsy market are Cardinal Health, Pfizer Inc., Merck & Co. Inc., Thermo Fisher Scientific Inc., AstraZeneca, Medtronic, Siemens Healthcare Private Limited, Becton, Dickinson and Company, Stryker Healthcare, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., Zimmer Biomet, Agilent Technologies Inc., Olympus Corporation, Hitachi High-Tech Corporation, Beckman Coulter Inc., B. Braun, Sysmex Corporation, Cook Medical, Bio-Rad Laboratories Inc., Integra LifeSciences Corporation, Merit Medical Systems, Leica Biosystems Nussloch GmbH, Argon Medical Devices Inc., BioGenex

What Is Fueling Growth in the Kidney Biopsy Market?

The increasing occurrence of renal cancer is anticipated to fuel the expansion of the kidney biopsy market in the future. Renal cancer, characterized by the uncontrolled multiplication of abnormal kidney cells, is on the rise due to factors like lifestyle changes, environmental toxins, and improved detection methods leading to increased diagnoses. Kidney biopsies play a crucial role in diagnosing and managing renal cancer by verifying cancerous cells, identifying the cancer grade, devising treatment plans, tracking treatment outcomes, and offering prognostic data. For example, Cancer Research UK, a UK-based organization for cancer research, predicts that new kidney cancer cases will rise from roughly 16,300 in 2023 to around 21,900 in 2025. Consequently, the escalating incidence of renal cancer is propelling the growth of the kidney biopsy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=16458&type=smp

Which Kidney Biopsy Market Segments Are Growing the Fastest?

The kidney biopsy market covered in this report is segmented –

1) By Type: Percutaneous Biopsy, Surgical Biopsy

2) By Indication: Kidney Failure, Kidney Transplant, Hematuria, Proteinuria

3) By End-User: Hospitals And Clinics, Urology Centers, Tertiary Care Centers, Other End-Users

Subsegments:

1) By Percutaneous Biopsy: Ultrasound-Guided Biopsy, CT-Guided Biopsy, MRI-Guided Biopsy

2) By Surgical Biopsy: Open Kidney Biopsy, Laparoscopic Kidney Biopsy

Which Industry Trends Are Shaping the Future of the Kidney Biopsy Market?

Notable companies within the kidney biopsy market are implementing cutting-edge platforms, leveraging the power of artificial intelligence (AI), to refine their diagnostic precision, optimize procedures, and better patient results. Artificial intelligence (AI) revolutionizes kidney biopsy processes by enhancing image interpretation, offering diagnostic assistance, facilitating treatment strategizing, providing predictive analysis, and accelerating kidney disease research. For example, Aiosyn, a software firm situated in the Netherlands, unveiled the innovative NephroPath platform in March 2024. The NephroPath platform employs computational pathology algorithms to scrutinize histological biomarkers in kidney biopsies, which encompasses the identification of tissue types, quantifying interstitial fibrosis, and accurately tallying and evaluating glomeruli. This AI-led scrutiny assures consistent, comprehensive, and replicable scoring of renal pathology biomarkers, surpassing the limitations associated with traditional scoring techniques and observational bias.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Which Countries Are Leading the Kidney Biopsy Market?

North America was the largest region in the kidney biopsy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16458

This Report Delivers Insight On:

1. How big is the kidney biopsy market, and how is it changing globally?

2. Who are the major companies in the kidney biopsy market, and how are they performing?

3. What are the key opportunities and risks in the kidney biopsy market right now?

4. Which products or customer segments are growing the most in the kidney biopsy market?

5. What factors are helping or slowing down the growth of the kidney biopsy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model